Literature DB >> 18765133

Prostate cancer and chronic prostatitis.

Jaspreet S Sandhu1.   

Abstract

Prostate cancer and chronic prostatitis are prevalent disorders in men. The cause of prostate cancer and chronic prostatitis is multifocal and diverse. Both disorders exhibit characteristic elevation of serum prostate-specific antigen, currently the primary screening test for prostate cancer. Prostate inflammation, regardless of cause, is the histopathologic hallmark of chronic prostatitis. In general, inflammation is associated with multiple cancers, and prostate inflammation, in particular, is a suggested factor in the development and progression of prostate cancer. This review addresses the link between chronic prostatitis and prostate cancer, especially as it relates to clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765133     DOI: 10.1007/s11934-008-0056-6

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  25 in total

1.  Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen.

Authors:  J M Potts
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

2.  Epidemiologic association between prostatitis and prostate cancer.

Authors:  Leslie K Dennis; Charles F Lynch; James C Torner
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

3.  A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study.

Authors:  S Lilly Zheng; Wennuan Liu; Fredrik Wiklund; Latchezar Dimitrov; Katarina Bälter; Jielin Sun; Hans-Olov Adami; Jan-Erik Johansson; Jishan Sun; Baoli Chang; Matthew Loza; Aubrey R Turner; Eugene R Bleecker; Deborah A Meyers; John D Carpten; David Duggan; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Journal:  Prostate       Date:  2006-10-01       Impact factor: 4.104

4.  Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men.

Authors:  R O Roberts; M M Lieber; T Rhodes; C J Girman; D G Bostwick; S J Jacobsen
Journal:  Urology       Date:  1998-04       Impact factor: 2.649

Review 5.  A review of clinical and pathological prostatitis syndromes.

Authors:  R O Roberts; M M Lieber; D G Bostwick; S J Jacobsen
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

6.  Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study.

Authors:  Edward W J Rowe; Marc E Laniado; Marjorie M Walker; Patel Anup
Journal:  BJU Int       Date:  2006-05       Impact factor: 5.588

7.  Treatment of chronic prostatitis lowers serum prostate specific antigen.

Authors:  Caleb B Bozeman; Brett S Carver; James A Eastham; Dennis D Venable
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

8.  Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer.

Authors:  K Okada; M Kojima; Y Naya; K Kamoi; K Yokoyama; T Takamatsu; T Miki
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

9.  Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?

Authors:  R Shah; N R Mucci; A Amin; J A Macoska; M A Rubin
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 10.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  12 in total

1.  The 4q27 locus and prostate cancer risk.

Authors:  Elizabeth A Tindall; Hoa N Hoang; Melissa C Southey; Dallas R English; John L Hopper; Graham G Giles; Gianluca Severi; Vanessa M Hayes
Journal:  BMC Cancer       Date:  2010-02-25       Impact factor: 4.430

2.  Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4.

Authors:  Jianghua Wang; Yi Cai; Long-Jiang Shao; Javed Siddiqui; Nallasivam Palanisamy; Rile Li; Chengxi Ren; Gustavo Ayala; Michael Ittmann
Journal:  Cancer Res       Date:  2010-12-17       Impact factor: 12.701

3.  Inflammation and p53: A Tale of Two Stresses.

Authors:  Andrei V Gudkov; Katerina V Gurova; Elena A Komarova
Journal:  Genes Cancer       Date:  2011-04

4.  Anti-inflammatory and antiproliferative activities of date palm pollen (Phoenix dactylifera) on experimentally-induced atypical prostatic hyperplasia in rats.

Authors:  Ahmed A Elberry; Shagufta T Mufti; Jaudah A Al-Maghrabi; Essam A Abdel-Sattar; Osama M Ashour; Salah A Ghareib; Hisham A Mosli
Journal:  J Inflamm (Lond)       Date:  2011-12-23       Impact factor: 4.981

Review 5.  The impact of obesity towards prostate diseases.

Authors:  Dyandra Parikesit; Chaidir Arief Mochtar; Rainy Umbas; Agus Rizal Ardy Hariandy Hamid
Journal:  Prostate Int       Date:  2015-11-24

6.  Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics.

Authors:  Rogier R Wildeboer; Christophe K Mannaerts; Ruud J G van Sloun; Lars Budäus; Derya Tilki; Hessel Wijkstra; Georg Salomon; Massimo Mischi
Journal:  Eur Radiol       Date:  2019-10-10       Impact factor: 5.315

7.  The Effect of Quercetin Nanosuspension on Prostate Cancer Cell Line LNCaP via Hedgehog Signaling Pathway.

Authors:  Nadia Mousavi; Shahrzad Rahimi; Hanane Emami; Amir Hossein Kazemi; Rana Mohammad Taghi Kashi; Ronak Heidarian
Journal:  Rep Biochem Mol Biol       Date:  2021-04

8.  Immunomodulatory effect of red onion (Allium cepa Linn) scale extract on experimentally induced atypical prostatic hyperplasia in Wistar rats.

Authors:  Ahmed A Elberry; Shagufta Mufti; Jaudah Al-Maghrabi; Essam Abdel Sattar; Salah A Ghareib; Hisham A Mosli; Salah A Gabr
Journal:  Mediators Inflamm       Date:  2014-04-13       Impact factor: 4.711

9.  Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.

Authors:  Ashley B Ward; Hina Mir; Neeraj Kapur; Dominique N Gales; Patrick P Carriere; Shailesh Singh
Journal:  World J Surg Oncol       Date:  2018-06-14       Impact factor: 2.754

Review 10.  Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy.

Authors:  Gianni Paulis
Journal:  Res Rep Urol       Date:  2018-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.